S-ketamine Infusion on Chronic Postoperative Pain Following Breast Cancer Surgery: A Randomized Double-Blind Placebo-Controlled Trial
Clinical Breast Cancer · 2024
DOI: 10.1016/j.clbc.2024.06.003 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Clinical Breast Cancer, 2024. Verfasst von Hao Guo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China; Department of Anesthesiology, Renmin Hospi…. Hauptthemen laut MEDLINE: Ketamine, Postoperative Pain, Breast Neoplasms, Mastectomy. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Themen: Schmerzmanagement
Abstract (Originalsprache)
BACKGROUND: Chronic postoperative surgical pain (CPSP) is a frequent complication following breast surgery and poses a challenge in terms of treatment. We hypothesized that the incidence of CPSP would be reduced at 3 months post-breast surgery with the administration of S-ketamine compared to a placebo. PATIENTS AND METHODS: Participants were recruited and randomly assigned to either the S-ketamine group (S) or the control group (C). In group S, S-ketamine was administered as a 1.5 mg kg-1 bolus followed by 2 mg kg-1h-1 infusion, while in group C, a placebo of 0.9% saline was administered in the same volume and rate as S-ketamine. The primary outcome was the incidence of CPSP, measured using a 0-10 numeric rating scale (NRS), at 3 months postsurgery. RESULTS: A total of 72 patients scheduled for mastectomy were enrolled (group S, n = 33; group C, n = 32). The incidence of CPSP at 3 months postsurgery was significantly lower in group S compared to group C (18.2% vs. 48.3%, P < .05). There was no statistical difference between the 2 groups in terms of the incidence of moderate to severe pain. NRS scores for postoperative pain at rest and during movement were significantly lower at 4 h and 24 h post-surgery (P < .05, respectively). Patients in Group S had lower Patient Health Questionnaire-9 (PHQ-9) scores at one week and 3 months post-surgery compared to Group C (P < .05, respectively). CONCLUSION: S-ketamine infusion reduces the incidence of CPSP 3 months after breast surgery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China; Department of Anesthesiology, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
- Department of Anesthesiology, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
- Department of Critical Care Medicine, Om Hospital and Research Center, Kathmandu, Nepal.
- Department of Anesthesiology, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei, China. Electronic address: ranran1146@163.com.
- Department of Anesthesiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China; Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, The First Affiliated Hosp…
Zitieren
APA
Guo, H., Zhang, X., Wang, J. G., Kalika, P., Ran, R., & Xie, Y. B. (2024). S-ketamine Infusion on Chronic Postoperative Pain Following Breast Cancer Surgery: A Randomized Double-Blind Placebo-Controlled Trial. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2024.06.003
Vancouver
Guo H, Zhang X, Wang JG, Kalika P, Ran R, Xie YB. S-ketamine Infusion on Chronic Postoperative Pain Following Breast Cancer Surgery: A Randomized Double-Blind Placebo-Controlled Trial. Clinical Breast Cancer. 2024. doi:10.1016/j.clbc.2024.06.003
BibTeX
@article{Guo2024,
author = {Guo, Hao and Zhang, Xi and Wang, Jia-Gao and Kalika, Prakash and Ran, Ran and Xie, Yu-Bo},
title = {S-ketamine Infusion on Chronic Postoperative Pain Following Breast Cancer Surgery: A Randomized Double-Blind Placebo-Controlled Trial},
journal = {Clinical Breast Cancer},
year = {2024},
doi = {10.1016/j.clbc.2024.06.003}
}
EUVIMED